DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by VELA Investment Management LLC

VELA Investment Management LLC lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 38.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 49,101 shares of the medical instruments supplier’s stock after selling 31,019 shares during the period. VELA Investment Management LLC’s holdings in DENTSPLY SIRONA were worth $932,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in XRAY. Pacer Advisors Inc. increased its position in shares of DENTSPLY SIRONA by 15,105.1% during the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of DENTSPLY SIRONA by 206.3% during the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Invenomic Capital Management LP acquired a new stake in shares of DENTSPLY SIRONA during the third quarter worth about $23,724,000. National Bank of Canada FI increased its position in shares of DENTSPLY SIRONA by 85.8% during the third quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock worth $44,059,000 after purchasing an additional 751,800 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of DENTSPLY SIRONA by 50.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier’s stock worth $55,900,000 after purchasing an additional 692,100 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Ratings Changes

XRAY has been the topic of several recent research reports. Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Morgan Stanley dropped their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Needham & Company LLC restated a “buy” rating and issued a $25.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, February 11th. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Finally, Evercore ISI restated an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Ten equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and an average target price of $24.50.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $17.15 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The business’s 50 day moving average is $18.90 and its two-hundred day moving average is $21.58. DENTSPLY SIRONA Inc. has a 12-month low of $17.09 and a 12-month high of $34.91. The stock has a market capitalization of $3.41 billion, a price-to-earnings ratio of -8.28, a PEG ratio of 1.80 and a beta of 0.96.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 3.73%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -30.92%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.